All News #Library
Biotech
Newleos Doses First Participant in UK Phase 1b NTX-1955 GAD Trial
01 Apr 2026 //
PHARMIWEB
Newleos Doses First Patient in SOAR Phase 2 Anxiety Study
06 Jan 2026 //
BUSINESSWIRE
Newleos Therapeutics Names Timothy Noyes President, CEO
21 Oct 2025 //
PHARMIWEB
Newleos Pharma CEO Donabedian Honored By Goldman Sachs At 2025
15 Oct 2025 //
PHARMIWEB
Newleos Therapeutics Advances Neuropsychiatric Pipeline Progress
30 Sep 2025 //
BUSINESSWIRE
Newleos Adds Stephen Brannan to Board, Updates on NTX-1955
23 Jul 2025 //
BUSINESSWIRE

Market Place
Sourcing Support